When should bone biopsy be considered to guide management in patients in whom you're differentiating osteoporosis and renal osteodystrophy?
This question is part of our collaboration with ACR Convergence 2025 to Continue the Conversation from the meeting. This question was inspired by the session "Updates in Osteoporosis: Where They 'Fall Short" by Dr. @Dr. First Last and Dr. @Dr. First Last. If you did not attend the meeting, information about Convergence On Demand can be found here.
1 Answer
Mednet Member
Nephrology · Indiana University School of Medicine
Answered on
This is a major issue in patients with advanced CKD. Definitive RCT treatment trials for osteoporosis had an inclusion criteria of a normal PTH and an exclusion criteria of elevated creatinine greater than 1.1 to 1.5 (depending on the study). Therefore, in patients with CKD 3 and more severe CKD, AN...
Join for free or sign in to see the full answer